Replimune Group Inc (NASDAQ:REPL) has a beta value of 0.69 and has seen 0.45 million shares traded in the recent trading session. The company, currently valued at $855.66M, closed the recent trade at $11.1 per share which meant it gained $0.13 on the day or 1.19% during that session. The REPL stock price is -53.15% off its 52-week high price of $17.00 and 41.98% above the 52-week low of $6.44. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.62 million shares traded. The 3-month trading volume is 1.31 million shares.
The consensus among analysts is that Replimune Group Inc (REPL) is Buy stock at the moment, with a recommendation rating of 1.11. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 5 have rated it as a Hold, with 5 advising it as a Buy. 0 have rated the stock as Underweight.
Replimune Group Inc (NASDAQ:REPL) trade information
Sporting 1.19% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the REPL stock price touched $11.1 or saw a rise of 1.86%. Year-to-date, Replimune Group Inc shares have moved 28.47%, while the 5-day performance has seen it change 15.03%. Over the past 30 days, the shares of Replimune Group Inc (NASDAQ:REPL) have changed 13.50%. Short interest in the company has seen 9.32 million shares shorted with days to cover at 6.54.
Wall Street analysts have a consensus price target for the stock at $27, which means that the shares’ value could jump 58.89% from the levels at last check today.. The projected low price target is $27.0 while the price target rests at a high of $27.0. In that case, then, we find that the latest price level in today’s session is -143.24% off the targeted high while a plunge would see the stock gain -143.24% from the levels at last check today..
Replimune Group Inc (REPL) estimates and forecasts
The company’s shares have lost -3.73% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -14.85% over the past 5 years. Earnings growth for 2025 is a modest 9.79% while over the next 5 years, the company’s earnings are expected to increase by 35.14%.
REPL Dividends
Replimune Group Inc is expected to release its next earnings report on 2025-May-22 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Replimune Group Inc (NASDAQ:REPL)’s Major holders
Insiders own 4.51% of the company shares, while shares held by institutions stand at 107.52% with a share float percentage of 112.60%. Investors are also buoyed by the number of investors in a company, with Replimune Group Inc having a total of 228.0 institutions that hold shares in the company. The top two institutional holders are BAKER BROS. ADVISORS LP with over 10.05 million shares worth more than $90.41 million. As of 2024-06-30, BAKER BROS. ADVISORS LP held 14.5193% of shares outstanding.
The other major institutional holder is PRICE T ROWE ASSOCIATES INC /MD/, with the holding of over 9.24 million shares as of 2024-06-30. The firm’s total holdings are worth over $83.13 million and represent 13.3496% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are T. Rowe Price New Horizons Fund, Inc. and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 6.05% shares in the company for having 4.67 shares of worth $51.95 million while later fund manager owns 1.99 shares of worth $22.14 million as of Mar 31, 2025 , which makes it owner of about 2.58% of company’s outstanding stock.
